BioNTech SE
Statements
Income Statement
All figures per share in EUR.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.74 | 6.14 | 0.78 | 0.54 | 5.09 | 4.95 | 0.76 | 1.08 | 6.35 | 3.67 | 0.47 | 0.42 | 10.43 | |
| 0.68 | 0.74 | 0.25 | 0.25 | 0.73 | 1.01 | 0.35 | 0.32 | 0.62 | 1.35 | 0.77 | 0.38 | 3.04 | |
| 3.06 | 5.39 | 0.53 | 0.29 | 4.36 | 3.94 | 0.41 | 0.76 | 5.73 | 2.32 | -0.30 | 0.03 | 7.39 | |
| 2.08 | 2.40 | 2.11 | 2.46 | 2.25 | 2.55 | 2.19 | 2.11 | 2.36 | 2.04 | 2.24 | 2.18 | 8.62 | |
| 0.58 | 0.55 | 0.49 | 0.72 | 0.54 | 0.46 | 0.44 | 0.49 | 0.51 | 0.99 | 0.49 | 0.62 | 2.54 | |
| 2.76 | 3.21 | 2.64 | 4.35 | 4.32 | 3.32 | 2.63 | 2.84 | 5.93 | 3.26 | 2.36 | 3.78 | 14.88 | |
| 0.30 | 2.18 | -2.11 | -4.06 | 0.04 | 0.62 | -2.22 | -2.07 | -0.20 | -0.94 | -2.66 | -3.74 | -7.49 | |
| 0.01 | 0.08 | 0.02 | 0.03 | 0.02 | 0.03 | 0.03 | 0.01 | 0.00 | 0.03 | 0.02 | 0.03 | 0.07 | |
| 0.95 | 2.75 | -1.38 | -3.39 | 0.65 | 1.25 | -1.85 | -1.67 | 0.10 | -0.92 | -2.28 | -3.39 | -6.46 | |
| 0.28 | 0.85 | -0.07 | 0.01 | -0.16 | 0.17 | -0.12 | -0.07 | 0.22 | 0.31 | -0.15 | -0.15 | 0.22 | |
| 0.67 | 1.90 | -1.31 | -3.40 | 0.81 | 1.08 | -1.73 | -1.60 | -0.12 | -1.23 | -2.14 | -3.24 | -6.68 | |
| 1.13 | 1.89 | -1.20 | -3.17 | 0.86 | 1.93 | -1.53 | -1.44 | 0.62 | -0.23 | -1.78 | -2.31 | -3.71 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.